Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …

Liquid biopsy is an emerging technology with a potential role in the screening and early
detection of lung cancer. Several liquid biopsy-derived biomarkers have been identified and …

The tumor-suppressor gene tumor protein p53 (TP53) is one of the most commonly mutated
genes in human lung cancer, and TP53 mutations are associated with a worsened …

Lung cancer is the most common cause of cancer deaths worldwide, and lung
adenocarcinoma (LUAD) is the most common histological subtype. However, the prognostic …

In this study, we established the predictive model for lung adenocarcinoma (LUAD)
depending on immune-related gene pairs (IRGPs) signature, which could not consider the …

Traditionally the stratification of many cancers involves combining tumour and
clinicopathological features (eg, patient age; tumour size, grade, receptor status and …

Lung cancer is the leading reason of cancer-related death from cancer globally for both men
and women. Recently, tumor immune heterogeneity has been implicated in cancer clinical …

In oncology, liquid biopsy is used in the detection of next-generation analytes, such as tumor
cells, cell-free nucleic acids and exosomes in peripheral blood and other body fluids from …

The marked heterogeneity of lung adenocarcinoma (LUAD) makes its diagnosis and
treatment difficult. In addition, the aberrant DNA methylation profile contributes to tumor …

Liquid biopsy, an innovative method for early diagnosis of cancer, has changed the
traditional method of diagnosing lung cancer and is considered a feasible auxiliary …